BMA calls for evidence on ethical implications of new genetic technologyBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7053.367c (Published 10 August 1996) Cite this as: BMJ 1996;313:367
- Richard Holloway
- Correspondence should be sent to the medical ethics department, BMA, BMA House, Tavistock Square, London WC1H 9JP.
EDITOR,—Few fields of medicine are developing as rapidly as human genetics. With such developments come new dilemmas and challenges for those working in health care. The BMA has recently established a multiprofessional steering group to examine the ethical implications of new genetic technology and to provide practical guidance for health professionals who are not specialists in genetics but who are increasingly being asked to advise on the implications of this technology.
The steering group is anxious to gather as much information as possible on current practice and the practical ethical problems that arise, from health professionals, counsellors, social workers, and lawyers. The group would welcome evidence of good practice and unresolved issues from any of these sources or from others who have experience of these issues.